All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings.
These reports are called 13F reports. However, the filings are required
the following quarter
from the reporting period,
which means that by the time the filing is made (and we see them), the information could be five months old.
For funds
with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover,
the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions
are identified in the table. However, they are not required to report short positions.
Click the link icon to see the full transaction history.
Upgrade
to unlock premium data and export to Excel
.
Security |
Imputed Share Price |
Prev Shares |
Current Shares |
Change (Percent) |
Prev Value (USD x1000) |
Current Value (USD x1000) |
Change (Percent) |
ACAD / ACADIA Pharmaceuticals Inc.
|
|
|
|
|
|
|
|
ACAD / ACADIA Pharmaceuticals Inc. Call
|
|
|
|
|
|
|
|
US00448Q2012 / Achillion Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
US00448Q2012 / Achillion Pharmaceuticals, Inc. Call
|
|
|
|
|
|
|
|
AGIO / Agios Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
AMPE / Ampio Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
ARROWHEAD RESH CORP
/ (042797209) |
|
|
|
|
|
|
|
BCRX / BioCryst Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
CCXI / ChemoCentryx Inc
|
|
|
|
|
|
|
|
FBIO / Fortress Biotech, Inc. Call
|
|
|
|
|
|
|
|
DSCI / Derma Sciences, Inc.
|
|
|
|
|
|
|
|
DYAX / Dyax Corp. Call
|
|
|
|
|
|
|
|
DYAX / Dyax Corp.
|
|
|
|
|
|
|
|
DVAX / Dynavax Technologies Corporation
|
|
|
|
|
|
|
|
ENTA / Enanta Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
ENZ / Enzo Biochem, Inc.
|
|
|
|
|
|
|
|
EPZM / Epizyme Inc
|
|
|
|
|
|
|
|
SGMO / Sangamo Therapeutics, Inc.
|
|
|
|
|
|
|
|
SGMO / Sangamo Therapeutics, Inc. Call
|
|
|
|
|
|
|
|
BLUE / bluebird bio, Inc.
|
|
|
|
|
|
|
|
HPTX / Hyperion Therapeutics Inc
|
|
|
|
|
|
|
|
KERX / Keryx Biopharmaceuticals, Inc.
|
|
|
|
|
|
|
|
KERX / Keryx Biopharmaceuticals, Inc. Call
|
|
|
|
|
|
|
|
MRTX / Mirati Therapeutics, Inc.
|
|
|
|
|
|
|
|
MYGN / Myriad Genetics, Inc.
|
|
|
|
|
|
|
|
LUMO / Lumos Pharma, Inc.
|
|
|
|
|
|
|
|
LUMO / Lumos Pharma, Inc. Call
|
|
|
|
|
|
|
|
NVAX / Novavax, Inc.
|
|
|
|
|
|
|
|
OCRX / Ocera Therapeutics, Inc.
|
|
|
|
|
|
|
|
OMER / Omeros Corporation
|
|
|
|
|
|
|
|
ACHV / Achieve Life Sciences, Inc.
|
|
|
|
|
|
|
|
PTCT / PTC Therapeutics, Inc.
|
|
|
|
|
|
|
|
RCPT / Receptos, Inc.
|
|
|
|
|
|
|
|
RMTI / Rockwell Medical, Inc. Put
|
|
|
|
|
|
|
|
SAVIENT PHARMACEUTICALS INC
/ NOTE 4.750% 2/0 (80517QAA8) |
|
|
|
|
|
|
|
SNMX / Senomyx, Inc.
|
|
|
|
|
|
|
|
VIRX / Viracta Therapeutics, Inc.
|
|
|
|
|
|
|
|
TGTX / TG Therapeutics, Inc.
|
|
|
|
|
|
|
|
TXMD / TherapeuticsMD, Inc.
|
|
|
|
|
|
|
|
TRANZYME INC
/ (89413J102) |
|
|
|
|
|
|
|
XOMA / XOMA Royalty Corporation
|
|
|
|
|
|
|
|
PRTA / Prothena Corporation plc
|
|
|
|
|
|
|
|
INSM / Insmed Incorporated
|
|
|
|
|
|
|
|